ArticleScientific reports2025
Construction and validation of a cross-sectional risk classification model for hypoproteinemia in single-center maintenance hemodialysis patient.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Hypoproteinemia is a common complication across patients receiving maintenance hemodialysis (MHD). Moreover, it is associated with increased risks of cardiovascular events, infection risk, and mortality. This study aimed to construct a classification model for identifying the risk of hypoproteinemia in MHD patients to support precise clinical interventions. To this end, a retrospective analysis was conducted on 288 MHD patients at the Affiliated Hospital of Jining Medical University (January-December 2023). Hypoproteinemia was defined as the primary outcome. Four machine learning (ML) models-Logistic Regression (LR), Random Forest (RF), Support Vector Machine (SVM), and eXtreme Gradient Boosting (XGBoost)-were trained and validated using 3-fold cross-validation. Feature selection was performed using the Least Absolute Shrinkage and Selection Operator (LASSO). Model performance was evaluated using area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, balanced F-score, and Brier score. SHapley Additive exPlanations (SHAP) was used to interpret the model. The SVM model demonstrated the highest identification performance with an AUC of 0.937. Thirteen key features were identified, with globulin, hemoglobin, β2 microglobulin, prealbumin, and hemodialysis mode being the most significant. In conclusion, the classification model based on ML can accurately identify the risk of hypoproteinemia in MHD patients and provide targeted guidance for early clinical intervention. The combination of SVM and SHAP not only enhances model interpretability but also establishes a scientific foundation for personalized risk classification and the development of precision diagnosis and treatment strategies by visualizing the dynamic effects of key features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.